1 - 25 of 3
Number of results to display per page
TitleCreatorDescriptionIdentifier
1 Electroretinography (ERG) Monitoring for Vigabatrin Visual Toxicity (The Pros and The Cons) - ERG versus No ERG with; Clinical Follow-Up (ERG Beneficial & ERG Not Beneficial)Steven F. Stasheff, MD, PhD; Michael J. Wan, MD, FRCSCPro: Eleven years ago, FDA approval of vigabatrin treatment for complex and refractory childhood epilepsy in the United States added substantially to previous experience in Europe, Canada and elsewhere. This experience has revealed both its utility in a wider variety of complex, refractory seizure d...20210223_nanos_controversiespediatricno1_01-abstract
2 Electroretinography (ERG) Monitoring for Vigabatrin Visual Toxicity (The Pros)Steven F. Stasheff, MD , PhEleven years ago, FDA approval of vigabatrin treatment for complex and refractory childhood epilepsy in the United States added substantially to previous experience in Europe, Canada and elsewhere. This experience has revealed both its utility in a wider variety of complex, refractory seizure disord...20210223_nanos_controversiespediatricno1_01-slidesa
3 Electroretinography (ERG) Monitoring for Vigabatrin Visual Toxicity (The Cons)Michael J. Wan, MD, FRCSCVigabatrin is a known cause of ocular toxicity and visual field loss. Early reports estimated ocular toxicity at 52% in adults and 34% in children. However, most early data was from small, retrospective studies and, crucially, many patients did not have baseline visual testing and had been on long-t...20210223_nanos_controversiespediatricno1_01-slidesb
1 - 25 of 3